IP Library Granted Patent US 8,394,760
Granted Patent B2
US 8,394,760 · App. 11/919,681 · Granted Mar 12, 2013

Multifunctional nanostructures, methods of synthesizing thereof, and methods of use thereof

Inventors: Lily Yang (Decatur, GA); Shuming Nie (Atlanta, GA); Xiaohu Gao (Shoreline, WA); Xiang Hong Peng (Stone Mountain, GA)
Assignee: Emory University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,760
App. No.
11/919,681
Granted
Mar 12, 2013
Kind
B2
Abstract

A nanostructure and methods of synthesizing same. In one embodiment, the nanostructure includes a nanospecies, a hydrophobic protection structure including at least one compound selected from a capping ligand, an amphiphilic copolymer, and combinations thereof, wherein the hydrophobic protection structure encapsulates the nanospecies, and at least one histidine-tagged peptide or protein conjugated to the hydrophobic protection structure, wherein the at least one histidine-tagged peptide or protein has at least one binding site.

Claims (23)

1. A nanostructure, comprising:

a. a quantum dot (QD);

b. a hydrophobic protection structure including at least one compound selected from a capping ligand, an amphiphilic copolymer, and combinations thereof, wherein the hydrophobic protection structure encapsulates the QD; and

c. at least one histidine-tagged peptide or at least one histidine-tagged protein, conjugated to the hydrophobic protection structure, wherein the at least one histidine-tagged peptide or protein has at least one binding site.

2. The nanostructure of claim 1 , wherein the amphiphilic copolymer is selected from amphiphilic block copolymers, amphiphilic random copolymers, amphiphilic alternating copolymers, amphiphilic periodic copolymers, and combinations thereof.

3. The nanostructure of claim 1 , wherein the amphiphilic copolymer is a block copolymer selected from a diblock copolymer, a triblock copolymer, and combinations thereof.

4. The nanostructure of claim 3 , wherein the amphiphilic block copolymer includes an ABC triblock structure having grafted 8-carbon alkyl side chains.

5. The nanostructure of claim 4 , wherein the ABC triblock structure includes a poly-butylacrylate segment, a poly-ethylacrylate segment, and a poly-methacrylic acid segment.

6. The nanostructure of claim 1 , wherein the amphiphilic copolymer has a molecular weight of about 50,000 Da to 200,000 Da, preferably about 100,000 Da.

7. The nanostructure of claim 1 , wherein the quantum dot comprises a core and a cap.

8. The nanostructure of claim 7 , wherein the core of the quantum dot is selected from the group consisting of IIA-VIA semiconductors, IIIA-VA semiconductors, IVA-IVA semiconductors, and IVA-VIA semiconductors.

9. The nanostructure of claim 7 , wherein the core of the quantum dot is selected from the group consisting of IIA-VIA semiconductors.

10. The nanostructure of claim 7 , wherein the core of the quantum dot is CdSe.

11. The nanostructure of claim 7 , wherein the cap is selected from the group consisting of IIA-VIA semiconductors of high band gap.

12. The nanostructure of claim 7 , wherein the cap is selected from ZnS.

13. The nanostructure of claim 1 , further comprising a bio-compatibility compound substantially disposed on the hydrophobic protection structure.

14. The nanostructure of claim 13 , wherein the bio-compatibility compound is a polyethylene glycol molecule having a molecular weight of about 500 Da to 50,000 Da.

15. The nanostructure of claim 1 , further comprising a probe disposed on the hydrophobic protection structure, wherein the probe is selected from an antibody, a polypeptide, a polynucleotide, a drug molecule, an inhibitor compound, and combinations thereof.

16. The nanostructure of claim 1 , wherein the capping ligand includes tri-octylphosphine oxide.

17. The nanostructure of claim 1 , further comprising a chelating compound for conjugating the at least one histidine-tagged peptide or protein to the hydrophobic protection structure by forming two or more coordinating bonding with the at least one histidine-tagged peptide or protein and the hydrophobic protection structure, respectively.

18. The nanostructure of claim 17 , wherein the chelating compound comprises nickel-nitrilotriacetic acid (Ni-NTA).

19. The nanostructure of claim 1 , wherein the at least one histidine-tagged peptide or protein comprises a histidine-tagged amino-terminal fragment (ATF) of urokinase plasminogen activator (uPA).

20. The nanostructure of claim 1 , wherein the binding site of the at least one histidine-tagged peptide or protein can be at the C-terminal, N-terminal or inside of the peptide or protein between two functional domains on the peptide or protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 28, 2010
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024457/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2008
From: YANG, LILY; NIE, SHUMING; GAO, XIAOHU; PENG, XIANG HONG
To: EMORY UNIVERSITY
Reel/Frame 021873/0192 →
Continuity (2)
Provisional Application 60676812 · May 2, 2005
Related Publication 20090123365A1 · May 14, 2009